搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Shewanella loihica Electron transport complex protein RnfG (rnfG), partial CSB-YP388780STO
CSB-EP388780STO
CSB-BP388780STO
CSB-MP388780STO
CSB-EP388780STO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella loihica Aspartate--tRNA ligase (aspS), partial CSB-YP388781STO
CSB-EP388781STO
CSB-BP388781STO
CSB-MP388781STO
CSB-EP388781STO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella loihica Ribonuclease H (rnhA) CSB-YP388782STO
CSB-EP388782STO
CSB-BP388782STO
CSB-MP388782STO
CSB-EP388782STO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella loihica Na (+)/H (+) antiporter nhaB, partial CSB-YP388783STO
CSB-EP388783STO
CSB-BP388783STO
CSB-MP388783STO
CSB-EP388783STO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella loihica Probable septum site-determining protein MinC (minC) CSB-YP388784STO
CSB-EP388784STO
CSB-BP388784STO
CSB-MP388784STO
CSB-EP388784STO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella loihica Imidazole glycerol phosphate synthase subunit HisH (hisH) CSB-YP388785STO
CSB-EP388785STO
CSB-BP388785STO
CSB-MP388785STO
CSB-EP388785STO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella loihica Imidazole glycerol phosphate synthase subunit HisF (hisF) CSB-YP388786STO
CSB-EP388786STO
CSB-BP388786STO
CSB-MP388786STO
CSB-EP388786STO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella loihica Recombination protein RecR (recR) CSB-YP388787STO
CSB-EP388787STO
CSB-BP388787STO
CSB-MP388787STO
CSB-EP388787STO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella loihica UPF0276 protein Shew_2240 (Shew_2240) CSB-YP388788STO
CSB-EP388788STO
CSB-BP388788STO
CSB-MP388788STO
CSB-EP388788STO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella loihica Probable intracellular septation protein A (Shew_2260), partial CSB-YP388789STO1
CSB-EP388789STO1
CSB-BP388789STO1
CSB-MP388789STO1
CSB-EP388789STO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella loihica S-adenosylmethionine:tRNA ribosyltransferase-isomerase (queA) CSB-YP388790STO
CSB-EP388790STO
CSB-BP388790STO
CSB-MP388790STO
CSB-EP388790STO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella loihica tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC (mnmC), partial CSB-YP388791STO
CSB-EP388791STO
CSB-BP388791STO
CSB-MP388791STO
CSB-EP388791STO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella loihica GTP cyclohydrolase-2 (ribA) CSB-YP388792STO
CSB-EP388792STO
CSB-BP388792STO
CSB-MP388792STO
CSB-EP388792STO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella loihica ATP-dependent Clp protease proteolytic subunit (clpP) CSB-YP388793STO
CSB-EP388793STO
CSB-BP388793STO
CSB-MP388793STO
CSB-EP388793STO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella loihica UDP-2,3-diacylglucosamine hydrolase (lpxH) CSB-YP388794STO
CSB-EP388794STO
CSB-BP388794STO
CSB-MP388794STO
CSB-EP388794STO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella loihica (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase CSB-YP388795STO
CSB-EP388795STO
CSB-BP388795STO
CSB-MP388795STO
CSB-EP388795STO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella loihica 30S ribosomal protein S2 (rpsB) CSB-YP388796STO
CSB-EP388796STO
CSB-BP388796STO
CSB-MP388796STO
CSB-EP388796STO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella loihica Protein Xni (xni) CSB-YP388797STO
CSB-EP388797STO
CSB-BP388797STO
CSB-MP388797STO
CSB-EP388797STO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella loihica 1-deoxy-D-xylulose-5-phosphate synthase (dxs), partial CSB-YP388798STO
CSB-EP388798STO
CSB-BP388798STO
CSB-MP388798STO
CSB-EP388798STO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella loihica Chaperone protein TorD (torD) CSB-YP388799STO
CSB-EP388799STO
CSB-BP388799STO
CSB-MP388799STO
CSB-EP388799STO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>